Funded Startups in Cambridge
Cambridge produces two distinct but equally active funding ecosystems: Cambridge, Massachusetts — anchored by MIT and Harvard's commercialization networks…
Cambridge produces two distinct but equally active funding ecosystems: Cambridge, Massachusetts — anchored by MIT and Harvard's commercialization networks — and Cambridge, UK, home to a dense cluster of spinouts from the University of Cambridge. The 50 most recent rounds in this dataset run from late June 2025 through late November 2025 and span both geographies. Biotechnology dominates by company count, with therapeutic-stage raises ranging from OutSee's $2M Seed (June 2025, UK) to Odyssey Therapeutics' $213M Series D (September 2025, MA). Artificial intelligence commands the largest individual round: Suno's $250M Series C closed November 22, 2025. Other headline figures include OpenEvidence at $210M Series B (July 2025), Vor Biopharma at $175M (June 2025), Strand Therapeutics at $153M Series B (August 2025), and UK-based Artios Pharma at $115M Series D (November 2025). Multiple rounds remain undisclosed, including FORAY bioscience, Sora Fuel, and Healx.
Most recent rounds
50 shownRelated listings
Frequently asked
What are the largest disclosed rounds among these Cambridge companies?
The three largest are Suno ($250M Series C, November 2025), Odyssey Therapeutics ($213M Series D, September 2025), and OpenEvidence ($210M Series B, July 2025), all Cambridge, MA. UK-based Artios Pharma closed a $115M Series D in November 2025, and Cambridge, MA's Lila Sciences raised $115M at Series A in October 2025. Strand Therapeutics ($153M Series B) and ARTBIO ($132M Series B) round out the top cluster, both closing in July–August 2025.
Are these companies based in Cambridge, Massachusetts or Cambridge, UK?
Both locations appear across the 50 rows. Cambridge, Massachusetts accounts for the majority of entries — including the largest rounds from Suno, Odyssey Therapeutics, and OpenEvidence. Cambridge, UK (Cambridgeshire) is well represented with significant rounds: Artios Pharma ($115M Series D), CuspAI ($100M Series A), and NRG Therapeutics ($68M Series B) are the largest UK-side raises in the set.
Which sector dominates funding activity in Cambridge right now?
Biotechnology is the most represented sector by a wide margin, spanning every stage from Seed (OutSee, $2M, June 2025) to Series D (Odyssey Therapeutics, $213M, September 2025). Artificial intelligence is the second most active cluster, with rounds including Suno ($250M Series C), Lila Sciences ($115M Series A), and CuspAI ($100M Series A). Several companies sit at the biotech-AI intersection, including Coherence Neuro and Flok Health.
What funding stages appear most frequently in this dataset?
Series A and the catch-all Series Unknown are the most common stage labels. Series A rounds in the set include CuspAI ($100M), Zag Bio ($80M), Lila Sciences ($115M), and nine others. Series Unknown covers a wide range of disclosed sizes — from Vor Biopharma's $175M and X4 Pharmaceuticals' $85M down to Curis' $7M — suggesting varied reporting conventions rather than a single stage profile.
Which Cambridge companies raised the largest rounds at early stages (Seed or Pre-Seed)?
Cambridge Terahertz led Seed-stage raises with $12M (July 2025, Cambridge, MA), followed by Vertical Semiconductor at $11M (October 2025). Coherence Neuro (UK) and Extuitive (US) each raised $10M and $20M at Seed, respectively. Pre-Seed activity was limited to two entries: Flok Health ($4M) and Möbius Industries ($4M), both closing in October–November 2025.
Is there any funding activity outside biotech and AI in Cambridge?
Yes, though it is a smaller share. Energy-focused companies include Fourth Power ($20M Series A, September 2025) and Sora Fuel (undisclosed, August 2025), both Cambridge, MA. Vertical Semiconductor ($11M Seed) and Cambridge Photon Technology ($1M, UK) represent hardware and materials. H2Ok Innovations raised $12M Series A in agriculture (July 2025), and hubflow raised $5M in real estate technology from Cambridge, UK.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.